Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 622.434M	--
Nov 6, 2024	2024/Q3	565.000M / 731.832M	--
Aug 8, 2024	2024/Q2	537.000M / 645.290M	--
May 9, 2024	2024/Q1	568.000M / 709.445M	--
Feb 15, 2024	2023/Q4	596.000M / 674.541M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 622.434M--

Nov 6, 20242024/Q3565.000M / 731.832M--

Aug 8, 20242024/Q2537.000M / 645.290M--

May 9, 20242024/Q1568.000M / 709.445M--

Feb 15, 20242023/Q4596.000M / 674.541M--

Unlock Free Earnings Estimates

Open Account

Royalty Pharma | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 09:27 ET

Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS THIRD QUARTER 2024 RESULTS

Nov 6, 2024 07:37 ET

Royalty Pharma | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 09:04 ET

Royalty Pharma | 8-K: ROYALTY PHARMA REPORTS SECOND QUARTER 2024 RESULTS

Aug 8, 2024 07:24 ET

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Updated: Dec 31, 2024

Strong Buy

No Data